CYP2E1 is related to the regulation of oxidant stress, insulin resistance and fatty acids, and the expression of hepatic CYP2E1 enhanced in patients with NAFLD (201). Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.